Showing results (271-280 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|March 1, 2024
Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor SensitivityLea M Korsholm, Maj Kjeldsen, Lorenzo Perino, et al.
JCO Precision Oncology|February 14, 2024
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry StudyCarmen J Calfa, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|February 23, 2024
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition SyndromesKeng Lam, Carlos Kamiya-Matsuoka, John M Slopis, et al.
JCO Precision Oncology|February 23, 2024
Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal CancerArndt Vogel, Karthikeyan Murugesan, Gajanan Kendre, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
JCO Precision Oncology|March 21, 2024
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency TestingAlejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara, et al.
JCO Precision Oncology|April 5, 2024
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment OutcomeKaterina-Marina Pilala, Georgios Kotronopoulos, Panagiotis Levis, et al.
JCO Precision Oncology|March 7, 2024
B-Cell-Mediated Immunity Predicts Survival of Patients With Estrogen Receptor-Positive Breast CancerSeungbok Lee, Byung-Hee Kang, Han-Byoel Lee, et al.
JCO Precision Oncology|March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With RuxolitinibAndrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
JCO Precision Oncology|July 22, 2024
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical AnalysisHajime Uno, Miki Horiguchi
Pageof 140